BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, July 18, 2025
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Australia and coronavirus

Australia bolsters diagnostics capability, surveillance in preparation for relaxing social distancing restrictions

May 1, 2020
By Tamra Sami
PERTH, Australia – Australia is taking several measures to increase diagnostic testing for COVID-19 and rolling out a national surveillance app as it prepares to relax social distancing measures and get back to work.
Read More
Photo of the the Breethe system

Abiomed up on solid earnings as it buys ECMO startup for heart pump combo, COVID-19 use

May 1, 2020
By Stacy Lawrence
The restrictions on elective surgeries as hospitals struggle to manage the unfolding global pandemic are hitting medical device companies particularly hard. Abiomed Inc., which specializes in a tiny, minimally invasive heart pump to support heart failure patients, saw its first fiscal fourth-quarter revenue flatten as procedures were postponed. Still, U.S. revenue remained stronger than Wall Street had expected, even as ex-U.S. revenue had deeper declines.
Read More
Coronavirus and stock charts

Stryker reports better-than-expected results despite impact of COVID-19

May 1, 2020
By Liz Hollis
Despite a drop off in elective procedures due to the COVID-19 pandemic, Stryker Corp., of Kalamazoo, Mich., unveiled first-quarter results that came in better than analysts had presumed. BTIG’s Ryan Zimmerman noted that, unlike other companies, Stryker did not pre-announce preliminary revenue. And while investors were concerned that the company would be adversely affected by the slump in elective procedures, "the diversity of the portfolio helped to offset procedure declines in late March.”
Read More

Regulatory actions for May 1, 2020

May 1, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bio-Rad, Quotient, Scibase.
Read More

Other news to note for May 1, 2020

May 1, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adeptrix, Avacta Group, Babson Diagnostics, Biolife Solutions, Biosig Technologies, Co-Diagnostics, Dermtech, Ipsum Diagnostics, Omega Bio-tek, Quantumdx Group Tandem Diabetes Care, Trinetx, Viewray.
Read More
EU flag and pills
Rolling with remdesivir

EMA begins remdesivir review, as CHMP recommends eight new meds for approval

May 1, 2020
By Michael Fitzhugh
The EMA's Committee for Medicinal Products for Human Use said Friday it has started a rolling review of Gilead Sciences Inc.'s antiviral, remdesivir, for the potential treatment of COVID-19. The move put into play one of multiple regulatory tools it has deployed "to speed up the assessment of a promising investigational medicine during a public health emergency."
Read More
Antibodies fighting coronavirus

Bio-Rad receives FDA emergency use go-ahead for COVID-19 total antibody test after submission

May 1, 2020
By Stacy Lawrence
Bio-Rad Laboratories Inc. has launched its SARS-CoV-2 Total Ab test, which is a blood-based assay to identify all the antibodies that are developed by the human body in response to the novel coronavirus SARS-CoV-2. Companies have been racing to offer serological tests that work to detect the antibodies developed during a COVID-19 infection that remain present in the blood after the initial infection clears.
Read More

Regulatory front for May 1, 2020

May 1, 2020
The latest global regulatory news, changes and updates affecting biopharma.
Read More

Other news to note for May 1, 2020

May 1, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: ADC, Agex, Aradigm, Bixink, Coimmune, Enzychem, Evergreen, Formula, Gilead, Inovio, Lixte, Lonza, Moderna, Oxford Biodynamics, Puma, Teva, Vivus, Xbiotech.
Read More

In the clinic for May 1, 2020

May 1, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: ADC, Akari, Astrazeneca, Athersys, Azurrx, BMS, Calcimedica, Eiger, Flexion, Ipsen, Kubota, Lilly, Merck, Novartis, Synairgen, TG.
Read More
Previous 1 2 … 466 467 468 469 470 471 472 473 474 … 548 549 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 17, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 17, 2025.
  • Multiple myeloma and antibodies

    Blenrep misstep? ODAC cites tox, GSK dosing neglect in MM

    BioWorld
    The rough ride presaged by briefing documents came to pass for GSK plc with the drug first approved by the U.S. FDA as Blenrep (belantamab mafodotin, bel-maf), as...
  • Atai Therapeutics discovers new 5-HT2A receptor partial agonists

    BioWorld Science
    Atai Therapeutics Inc. has synthesized new tetrahydro pyridine-substituted indole and azaindoles acting as 5-HT2A receptor partial agonists reported to be useful...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 15, 2025
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing